Immunodeficiency-Related Malignant Neoplasm

Immunodeficiency-Related Malignant Neoplasm — Trials · CancerIndex

Clinical trials

Registered studies

79 studies whose conditions map to this entity or one of its descendants. Status and phase are as posted on ClinicalTrials.gov. 50 studies per page.

Active: 15
Recruiting: 5
Ph III recruiting: 0
Growth YoY: —
Industry share: 7%
Top sponsor: AIDS Malignancy Consortium
Termination share: —

Computedformula ci-trial-intel-v1 · interventional studies · entity + NCIt descendants · hover a figure for its formulaCompare cancers Terminated studies (14)

clinicaltrialsPublishedShowing 1–5 of 5 studies matching the filters · status and phase as posted by the registrant; each row links to the study record.

NCT	Title	Status	Phase	Enrollment (n)	Sponsor	Countries	Last update	Source
NCT07563010	Menin-Inhibitor Targeted Maintenance in AML	not yet recruiting	Phase 2	146	Center for International Blood and Marrow Transplant ResearchNETWORK	0	Jun 22, 2026	clinicaltrials
NCT04929028	Therapy Adapted for High Risk and Low Risk HIV-Associated Anal Cancer	active not recruiting	Phase 2	40	National Cancer Institute (NCI)NIH	1	Jun 17, 2026	clinicaltrials